Matters Arising

Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter

Mark S Schmidt et al. · Nature Metabolism · 2019

Evidence type: Cellular and structural study Interpretive weight: Mechanistic contextResearch area: NMN transport mechanisms
DesignMatters Arising / mechanistic critique of the SLC12A8 transporter claim
PopulationNot applicable; analysis and interpretation of published transporter evidence
SampleNot applicable.
InterventionNot applicable.
EndpointsEvaluation of evidence for SLC12A8 as an NMN transporter; Comparison with NMN dephosphorylation and NR uptake evidence; Transporter kinetics and annotation

What the publication reported

This Nature Metabolism Matters Arising challenged the claim that SLC12A8 had been established as a specific NMN transporter.

Schmidt and Brenner argued that prior genetic, pharmacological and kinetic evidence supported NMN dephosphorylation to nicotinamide riboside before cellular internalization and that the SLC12A8 data did not adequately demonstrate specific NMN transport.

The existence of this formal published disagreement means the Evidence Center should describe the NMN-transporter question as contested rather than settled.

Key findings

  • The authors disputed the evidence that SLC12A8 specifically transports NMN.
  • They emphasized prior evidence supporting extracellular NMN dephosphorylation before cellular uptake.
  • They argued that SLC12A8's known transporter annotation and available kinetic data did not establish the proposed role.
  • The article directly responds to Grozio et al. 2019.

What it cannot establish

  • This is a Matters Arising critique rather than a standalone intervention study.
  • It evaluates and interprets existing mechanistic evidence.
  • Later experimental work may further refine the transporter question.
  • The article does not determine human clinical efficacy or oral supplement outcomes.
HealthspanX claim boundary: This critique does not prove a single alternative human uptake mechanism; it shows that the SLC12A8 transporter claim should not be treated as settled.

Continue reviewing

Return to the complete evidence library.

Source fields verified